Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2022-10-01
2023-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Do MRI derived images of stomach contents at low magnetic field (0.5 Tesla) have sufficient resolution to provide a reproducible assessment of gastric emptying
* What is the agreement and relationship between the rate of gastric emptying determined from the 2 methods Participants will be asked to attend the imaging centre on one occasion in the morning after fasting from midnight and to sit within an upright MRI scanner for a period of approximately 140 minutes. Images of their stomach will be taken before and for 2 hours after consuming a drink containing glucose and a small amount of sodium acetate which contains a heavier form of carbon. Before each image is taken, participants will be asked to exhale into a 500ml bag to collect a breath sample.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
NCT05508126
Energy CT in Imaging and Diagnosis of Gastric Cancer
NCT06869694
Role of 18F-FDG PET/CT in Gastric Cancer
NCT05687552
PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
NCT04762719
PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans
NCT00222768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy adults
Healthy male and female participants
Oral glucose tolerance test
A drink containing 75g of glucose together with 150mg carbon-13 sodium acetate in 300ml water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral glucose tolerance test
A drink containing 75g of glucose together with 150mg carbon-13 sodium acetate in 300ml water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to fully comprehend the informed consent process and give informed consent.
* BMI \<30 kg/m2
Exclusion Criteria
* Major psychiatric, cognitive or mood disorder.
* Any other significant chronic medical conditions, including diabetes (type 1 and 2), asthma and epilepsy.
* Any acute major illness or surgery within one year prior to participation.
* Glucose intolerance (as assessed by a finger-prick test at screening).
* Having taken part in a research study in the last 3 months involving invasive procedures, ionising radiation or an inconvenience allowance.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luca Marciani
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luca Marciani, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Nottingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sir Peter Mansfield Imaging Centre
Nottingham, Notts, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40-0822
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.